Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Screening and Preventive Intervention for Latent TB in Children
NCT04156568Phase 1Unknown
- Sponsor
- Beijing Children's Hospital
- Start
- Nov 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of rifapentine in Tuberculosis (TB) (2 arms), sponsored by Beijing Children's Hospital. Primary endpoints: Morbidity (Incidence of active tuberculosis) at 2 years, Proportion of adverse reactions at 2 years and 1 more. Status: unknown.
02
Drugs
rifapentine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04156568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156568.